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Hypertonic Na+ accumulation in peripheral tissues is a recently described phenomenon: it
has been associated with ageing, hypertension, diabetes, chronic kidney disease and heart
failure, but its clinical meaning has yet to be determined. This concept conflicts with the
classic physiological paradigm of constant balance between salt intake and excretion, and
its water-independent nature is still a matter of debate.
We developed a theoretical model explaining changes in the chemical composition of tissues
as a function of extracellular volume fraction and excess extracellular fluid, i.e. oedema. The
model suggests that the proportional increase in absolute Na+ content and concentration
due to different degrees of oedema is higher than the parallel increase in water content, thus
making Na+ a more sensitive index to detect this oedema.
Our model would explain some of the recent findings of high tissue Na+ content in patho-
logical conditions. More importantly, it prompts the reappraisal of tissue Na+ analysis from
being a topic of niche interest to a potential diagnostic tool with broad applicability in the
investigation of subclinical systemic and localized oedema.
A paradigm shift: from equilibrium to local hypertonic
sodium accumulation
Classic physiology advocates the ultimate achievement of a constant balance between salt intake and ex-
cretion. At variance, over the last few years work by Titze and his collaborators has highlighted the phe-
nomenon of hypertonic sodium (Na+) accumulation in peripheral tissues. Having observed considerable
changes in total body Na+ without corresponding changes in body weight in a human long-term balance
study [1], they first proposed skin as an extensive depot for water-independent Na+ storage based on
studies in rodents [2]. Further preclinical investigations identified local regulatory mechanisms, entailing
glycosaminoglycans as the putative binding site and tonicity-dependent modulation of skin lymphatic
vessels as a buffering system [3,4], as well as the hypertensive phenotype associated with their disruption.
Availability of 23Na-magnetic resonance imaging (23Na-MRI) allowed translation back to humans: an
increase in skin Na+ content occurs with ageing; in patients with refractory hypertension or primary al-
dosteronism compared to normotensive controls [5,6]; and in other clinical conditions such as acute heart
failure [7], systemic sclerosis [8] and diabetes [9]. Skin Na+ also correlates better than total body overhy-
dration or blood pressure with left ventricular mass in patients with chronic kidney disease [10], thus
stimulating the quest for interventions specifically targeting tissue Na+ to improve cardiovascular out-
comes in this population.
Overall, this new notion of local Na+ accumulation was acknowledged by independent influential re-
ports as a paradigm shift [11,12], closely linked to the enormous public health burden of ageing and
cardiovascular disease, which deserves a clearer understanding [12].
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A Na+ model beyond the skin
The above MRI studies, which were all performed in the lower leg, revealed an increase in 23Na signal not only in
the skin but also in the skeletal muscle [6,7,9]; this is at odds with mechanisms for hypertonic Na+ accumulation,
described as skin-specific in the preclinical studies.
In an attempt to studywhether a similar phenomenon could be generalized to other tissues, we analyzedmyocardial
water and total electrolyte composition in a rodent model of ageing and hypertension [13]. After tissue digestion, we
observed an increase in tissue Na+ content and concentration, which was not hypertonic, but paralleled by water
accrual and an associated decrease in potassium (K+) concentration, previously described by others as a ‘loss’ [2].
We, therefore, developed a simple mathematical model (Supplementary Information for calculations) for predict-
ing total Na+ and K+ composition of any tissue, as a function of the extracellular volume fraction (ECV%): intuitively,
the higher the ECV% (i.e. the proportion of the Na+-rich extracellular solution), the higher the total concentration
of Na+ in the ‘final solution’ from whole tissue (Figure 1, left panel, open circles). Vice versa, the decrease in K+ con-
centration is explained by a proportionally less represented intracellular, K+-rich compartment (Figure 1, left panel,
open squares), without any ‘loss’.
More importantly, we interpreted the increase in water content and the overall unchanged sum of Na+ and K+ in
our experiment as ‘isotonic’ oedema. Accordingly, we challenged the above model by simulating the effect of adding
a fixed and biologically plausible moiety of fluid (e.g. 1%, 2.5% or 5%), equal in composition to the extracellular
Na+-rich solution, to the tissues (i.e. oedema). This shifted the curves up for Na+ and down for K+, as expected from
the equivalent of a global increase in ECV% (Figure 1, left panel, closed symbols for 5% oedema). Unexpectedly,
however, we also noted that the proportional increase in tissue Na+ concentration due to oedema was much higher
than the increase in water in tissues where the ECV% is low, such as skeletal muscle and myocardium with an ECV%
of 16–20% and 25–30%, respectively (Figure 1, right panel; black lines). This phenomenon is even more pronounced
and holds true across all the spectrum of possible ECV% when absolute Na+ content, rather than concentration, is
taken into account (Figure 1, right panel; red lines).
With due consideration of experimental variability, this theoreticalmodel is in keepingwith data fromus and others
[2–4,13,14]. Moreover, the concept of a ‘final solution’ applies to chemical analysis of ashed [2,4] and/or digested
[13] tissues, but also to any other technique that does not allow (accurate) spatial differentiation of intracellular and
extracellular compartments. This is the case forMRI voxels in clinical practice: apart from some approaches currently
limited to research [15,16], 23Na-MRI only offers ‘total’ 23Na signal thus far. Indeed, measurement of absolute changes
(i.e. red lines; Figure 1) rather than concentration is much closer to what MRI actually does when recording signals
from single atoms. Recent evidence of higher sensitivity of 23Na-based analysis over standard 1H T2 MRI approaches
to monitor acute ischaemic extracellular compartment changes within skeletal muscle in humans [15] supports our
contentions.
Implications of the model
In our view this model has broad and important implications.
First, relative differences and/or changes in the proportion of intracellular and extracellular compartments in a
tissue affect total tissue Na+ and K+ concentrations per se.
Second, as long as one has valid tools for its measurement (e.g. tissue chemical analysis by flame photome-
try/absorption spectroscopy or non-invasive MRI), Na+ can be much (up to 3.5–4 times) more sensitive than water
itself to detect oedema. Therefore, it is no more acceptable to claim solely for a ‘more pronounced Na+ – than water –
accumulation’ [14] to support its water-free, hypertonic nature. In fact, when parallel changes in skin or muscle water
content were carefully examined, despite sometimes lacking statistical significance due to the difference in sensitivity
described above, they could often be detected [9,10,13].
Third, as an Occamian consequence of the two above, our model could justify most of the proportionally higher
increase in Na+ moles or 23Na-MR signal in tissues observed thus far, without the need for it to represent a novel,
water-independent phenomenon. Skin and particularly the relatively acellular, glycosaminoglycans-rich dermis,
where an excess of total osmolytes has beenmore convincingly demonstrated [2–4,14], are possible exceptions, which
could offer a depot for a Na+ excess storage at least in part hypertonic [17]. With this regard, a parallelism between
the physiology of kidney and skin, both acting as ‘barrier’ organs, has been suggested [18]. However, we wonder how
much of that Na+ excess is due to the accumulation of Na+ itself or, rather, to a relative deficit of water which went lost
at the barrier at some point and left its accompanyingNa+ behind. In line with this argument, the finalistic dominance
of body water – over Na+ – homeostasis has been recently reappraised [19].
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Figure 1. Model for chemical composition of tissues and impact of oedema
Left panel: Expected total concentration of Na+ (open circles) and K+ (open squares) in a tissue, before and after addition of
5% of oedema (closed squares and circles, respectively), as a function of the extracellular volume fraction (ECV%). Values for
representative tissues with different ECV%are shown in dashed boxes. Right panel: Percentage change of tissue Na+ concentration
(black) or absolute content (red) after addition of 1% (dotted line), 2.5% (dashed line) or 5% (continuous line) oedema to the tissue,
as a function of the extracellular volume fraction (ECV%).
These speculations could possibly in part reconcile contrasting positions within the field of salt research. In par-
ticular, our work does not aim to disprove the occurrence of any hypertonic Na+ accumulation at all, but to highlight
that the high salt tissue signal observed in ageing, uncontrolled and/or secondary hypertension, diabetes, CKD, heart
failure and systemic sclerosis is likely to be (at least in a considerable part) a different phenomenon. In a sense, to the
‘hypothetical framework’ described by Bhave and Neilson [17] to explain ‘real’ water-independent Na+ storage, our
model adds another but seemingly highly prevalent mechanism for ‘apparent’ water-independent Na+ storage.
Furthermore, ofmuch broader interest to themedical community at large, ourmodel could help address the largely
unmet need to diagnose subclinical and/or local oedema, as outlined below.
The potential for ‘isotonic’ Na+ excess investigation
Systemic (subclinical) congestion
The 23Na-MRI data collected in different patient populations at-risk-of [6,7,9,10] or with clinically overt heart failure
[6,7,9,10], together with the chemical data in our rodent model of ageing and hypertension, point to a common
increase in tissue Na+ content and, as a consequence of the model, to subclinical congestion. We now interpret many
of the aforementioned ‘at–risk’ patients as affected by subclinical (or clinically unrecognized) heart failure that tissue
Na+ analysis could make evident.
Classic diuretic interventions (i.e. loop-diuretics) or novel approaches such as SGLT2-inhibition, which ultimately
produces a natriuretic/diuretic-like effect, are both effective in reducing tissue Na+ [7,9]. It therefore comes as no sur-
prise that the former is the cornerstone for heart failure treatment and the latter offered tremendous and unexpected
c© 2018 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons
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reduction in incident heart failure hospitalizations and deaths, even when used in not-overtly congested diabetic
patients [20].
Local oedema
In addition to the cardiovascular field, appreciation of the direct link between the 23Na signal and oedema and of
its higher sensitivity to detect oedema compared with water (Figure 1, right panel; red lines) prompts development
of multiple 23Na-MRI applications also in the whole range of diseases where mechanical or inflammatory localized
oedema is implicated, including rheumatological, immunological, oncological and neurological conditions. As an
example, both global and regional differences in total 23Na brain signal were found in multiple sclerosis patients
compared to controls [16]. The diagnostic potential, even if more sophisticated analysis of intra-extracellular Na+
transmembrane regulation within lesions is still limited to research, seems obvious: 23Na-MRI could represent a
radionuclide-free, ‘endogenous’ PET for early (or late) oedema. In addition, relatively inexpensive chemical inves-
tigation in preclinical models might similarly help identifying and addressing early stages of diseases.
Conclusions
In conclusion, we acknowledge that our model lacks the detailed insights discussed extensively in many physiological
reviews by others, for example in terms of interstitial dynamics and biophysical properties [17]. However, it provides
a pragmatic, deliberately simple but also clear-cut demonstration that the sole addition of an extra moiety of fluid,
equal in composition to the extracellular, i.e. oedema, has a considerable impact on total tissue Na+ per se. As a result,
the model offers a somewhat ‘traditional’, water-paralleled perspective on what appeared as a ‘new’ phenomenon.
While our hypothesis obviously warrants further validation, we believe there is clinical utility for tissue-Na+ analysis
beyond the physiology laboratory. Our paradigm could be useful in many clinical disciplines where oedema is a key
pathological component.
Clinical perspectives
• Tissue accumulation of sodium is a recently described phenomenon and is thought to be associ-
ated with a wide range of cardiovascular diseases. It has been suggested to be water independent
but remains incompletely understood.
• Based on a simple model of the chemical (water and cations) content of tissue, we demonstrate
that changes in the proportion of intracellular and extracellular compartments in a tissue affect
total tissue Na+ and K+ concentrations per se and that sodium is intrinsically more sensitive than
water itself to identify oedematous conditions.
• Our model could provide an explanation that could explain the high tissue sodium content found
in different pathological conditions. More importantly, tissue sodium analysis has broad potential
in the early diagnosis of subclinical and/or localized oedema.
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